✍ Scribed by Toyoaki Tenzen; Filip Zembowicz; Chad A. Cowan
No coin nor oath required. For personal study only.
Induced pluripotent stem cell (iPSC) technology has emerged as the most promising method for generating patient‐specific human embryonic stem (ES) cells and adult stem cells (Takahashi et al., 2007, Cell 131:861–872; Wernig et al., 2007, Nature 448:318–324; Park et al., 2008, Nature 451:141–146). So far, most studies of direct reprogramming have been done by using lentiviruses/retroviruses encoding the reprogramming factors. This represents a major limitation to therapeutic applications since viral integration in the host genome increases the risk of tumorigenicity, and low‐level residual expression of reprogramming factors may alter the differentiation potential of the human iPSCs (hiPSCs). As a result, more attention has been paid to developing new techniques to manipulate the human genome, with the goal of making safer hiPSCs that have fewer or no lesions or alterations in the genome. Additionally, the efficiency of reprogramming and of homologous recombination in gene therapy must be improved, if iPSC technology is to be a viable tool in regenerative medicine. Here, we summarize the recent developments in human genome manipulation for generating hiPSCs and advances in homologous recombination for gene targeting. J. Cell. Physiol. 222: 278–281, 2010. © 2009 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Availability of human embryonic stem cells (hESC) has enhanced human neural differentiation research. The derivation of neural progenitor (NP) cells from hESC facilitates the interrogation of human embryonic development through the generation of neuronal subtypes and supporting glial ce
## Abstract Human embryonic stem (HES) cells are pluripotent and give rise to any cell lineage. More specifically, how the first embryonic lineage (i.e., cardiac lineage) is acquired remains in many aspects questionable. Herein, we summarize the protocols that have been used to direct the fate of H
## Abstract The unique properties of embryonic stem cells (ESCs) to self‐renew indefinitely or to differentiate to any cell type have great potential for clinical applications in regenerative medicine. MicroRNAs (miRNAs) are emerging as important regulators of post‐transcriptional gene expression a
## Abstract The recent isolation of human embryonic stem (ES) cells is evoking great hopes for their future utilization in cell‐replacement therapies and human development research. The hallmarks of ES cells, pluripotency and self‐renewal capacity, suggest an infinite source for tissues of virtuall